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MHC Class I-Restricted Presentation of Maleylated Protein
Binding to Scavenger Receptors1
Pratima Bansal,2,3 Paushali Mukherjee,2 Sandip K. Basu, Anna George, Vineeta Bal, and
Satyajit Rath4
Pathways for loading exogenous protein-derived peptides on MHC class I are thought to be present mainly in monocyte-lineage
cells and to involve phagocytosis- or macropinocytosis-mediated antigenic leakage into either cytosol or extracellular milieu to give
peptide access to MHC class I. We show that maleylation of OVA enhanced its presentation to an OVA-specific MHC class
I-restricted T cell line by both macrophages and B cells. This enhanced presentation involved uptake through receptors of
scavenger receptor (SR)-like ligand specificity, was TAP-1-independent, and was inhibited by low levels (2 mM) of ammonium
chloride. No peptide loading of bystander APCs by maleylated (maleyl) OVA-pulsed macrophages was detected. Demaleylated
maleyl-OVA showed enhanced MHC class I-restricted presentation through receptor-mediated uptake and remained highly
sensitive to 2 mM ammonium chloride. However, if receptor binding of maleyl-OVA was inhibited by maleylated BSA, the residual
presentation was relatively resistant to 2 mM ammonium chloride. Maleyl-OVA directly introduced into the cytosol via osmotic
lysis of pinosomes was poorly presented, confirming that receptor-mediated presentation of exogenous maleyl-OVA was unlikely
to involve a cytosolic pathway. Demaleylated maleyl-OVA was well presented as a cytosolic Ag, consistent with the dependence of
cytosolic processing on protein ubiquitination. Thus, receptor-specific delivery of exogenous protein Ags to APCs can result in
enhanced MHC class I-restricted presentation, suggesting that the exogenous pathway of peptide loading for MHC class I may be
a constitutive property dependent mainly on the quantity of Ag taken up by APCs. The Journal of Immunology, 1999, 162:
4430–4437.
P eptides from proteins exogenous to APCs are usually pre-sented on MHC class II, while those from APC-endoge-nous proteins are presented on MHC class I. Exogenous
proteins are taken up by various endocytic processes from the ex-
tracellular milieu and degraded in the endolysosomal compart-
ments, and the resultant peptides are bound to MHC class II in
these compartments (1). Endogenous cytosolic proteins are de-
graded predominantly by a ubiquitin-ATP-proteasome-dependent
pathway (2) in the cytosol, and the peptides are then transported by
TAP (3, 4) into the endoplasmic reticulum (ER)5 (5–8), where
they bind to nascent MHC class I and the stable assembly is trans-
ported to the cell surface (9).
However, several exceptions to these rules segregating MHC
class I and class II presentation pathways have been reported.
Some endogenous protein-derived peptides are known to be pre-
sented on MHC class II (10–14), and there are reports of presen-
tation of peptides derived from soluble, exogenous proteins on
MHC class I. Cytotoxic CD8 responses could be generated by
pathogens resident in the phagolysosomal compartments of APCs
(15, 16), as well as by soluble OVA (17), suggesting the existence
of a mechanism for presentation of exogenous Ags on MHC class
I. Macrophages were initially thought to be the only APC capable
of such presentation, and B cells were shown to be incapable of it
(18–20). However, similar properties have now been described for
dendritic cells (21, 22), fibroblasts (23), and mast cells (24).
The ability of most of these APC types to present exogenous Ag
on MHC class I still appears dependent on their phagocytic abil-
ities (18–24). It is not clear whether this correlation with phago-
cytosis is simply due to the advantage of achieving high concen-
trations of Ag in the APC, or whether specific cell biological
properties of phagosomes are crucial, since the processing mech-
anisms involved are not yet unambiguously understood. Various
pathways have been reported for processing of exogenous Ag for
presentation on MHC class I. According to the endosomal pro-
cessing model, exogenous proteins are processed in the endosomal
compartments, and peptides are then regurgitated, as a peculiar
property of macrophages and dendritic cells, into the extracellular
milieu to associate with surface MHC class I (25). The cytosolic
processing model depends on formation of leaky phagosomes (23,
26) and/or leaky macropinosomes (27), allowing escape of pro-
teins from endosomal fluid into the cytosol, with subsequent cy-
tosolic processing of Ags via the conventional proteasome- and
TAP-dependent pathway (26, 27). In accordance with the endoso-
mal model, one report finds Ags encapsulated in acid-sensitive
liposomes to be presented on MHC class I more efficiently than
acid-resistant ones (28), while another report finds Ags in both
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acid-sensitive and acid-resistant liposomes presented equally well
on MHC class I, as would be expected by the cytosolic model (29).
We have been analyzing the consequences of Ag delivery to
various APCs via SR-mediated endocytosis (30–32) for presenta-
tion on MHC class II to various APCs and have now extended
these studies to the effects of such SR-mediated uptake on MHC
class I-restricted presentation and to the pathways used in such
presentation.
Materials and Methods
Mice
C3H/HeJ (H-2k) and C57BL/6 (H-2b) mice (The Jackson Laboratory, Bar
Harbor, ME), as well as TAP-1-deficient (TAP-1-KO) mice (H-2b, gift of
Dr. L. van Kaer, Vanderbilt University, Nashville, TN) bred in the small
animal facility of the National Institute of Immunology (New Delhi, India),
were used for experiments at 6–10 wk of age.
Antigens
OVA (Sigma, St. Louis, MO) was dialyzed extensively against PBS to
remove small degradation products. OVA or BSA were maleylated with
maleic anhydride (Sigma) at alkaline pH as previously described (33), fol-
lowed by extensive dialysis against PBS. The degree of maleylation was
assessed by estimating the loss of free e-amino groups as measured by
trinitrobenzenesulfonic acid (34). Maleyl-OVA or maleyl-BSA were used
only when maleylation was .95%. Demaleylation was performed at pH
3.5 as described (33). The demaleylated maleylated (de-maleyl)-OVA used
showed regeneration of .90% of the active e-amino groups of OVA as
measured by the trinitrobenzenesulfonic acid assay (34). In addition to
maleyl-BSA, the SR ligands fucoidin and polyguanylic acid (polyG) (Sig-
ma) were also used where appropriate.
Cell lines
The MHC class I (H-2Kb)-restricted, OVA-specific T cell transfectant
(B3.4.5) was a gift from Drs. C. Hogquist and M. Bevan (University of
Washington, Seattle, WA). It recognizes the OVA peptide 257–264,
SIINFEKL. The IL-2-dependent T cell line, CTLL-2, was obtained from
the American Type Culture Collection (ATCC; Manassas, VA).
Cytosolic delivery of Ags by osmotic lysis of pinosomes
Proteins were delivered into the cytosol using osmotic lysis of pinosomes
as described (35). Briefly, APCs were incubated in hypertonic solution (0.5
M sucrose, 10% polyethylene glycol 800, and 10 mM HEPES) containing
10 mg/ml of Ag in serum-free medium (DMEM; Life Technologies, New
Delhi, India) for 10 min at 37°C, followed by incubation in isotonic serum-
free medium for 5 min. Cells were then thoroughly washed before being
fixed with 1% paraformaldehyde (Sigma) for 1 min, washed, and used as
APCs in T cell stimulation assays.
Preparation of cellular subpopulations
Peritoneal exudate cells were elicited from C57BL/6 and TAP-1-KO mice
by i.p. injection of 4% Brewer’s thioglycollate broth (HiMedia, Mumbai,
India) and by performing peritoneal lavage 72 h later with 10 ml chilled
PBS. Macrophages were isolated by plastic adherence for 1 h. Splenic B
cells were isolated from plastic adherence-depleted single-cell suspensions
of splenic cells by labeling them with either anti-B220-biotin (PharMingen,
San Diego, CA) followed by streptavidin-coupled magnetic beads or anti-
CD19-coupled magnetic beads (Miltenyi Biotec, Bergisch-Gladbach, Ger-
many) for separation on magnetic columns (Miltenyi Biotec). Macrophage
and B cell preparations were monitored flow cytometrically and used at
.95% purity.
Ag presentation assays
B3.4.5 cells (1 3 105/well) were stimulated either with titrated doses of
OVA, maleyl-OVA, or de-maleyl-OVA presented by various APC types,
or with titrated numbers of APCs exogenously or cytosolically loaded with
various Ags in triplicate cultures. Culture supernatants were collected
24–36 h later. The amount of IL-2 induced was measured by the prolif-
erative responses of CTLL-2 cells and is shown as proliferation (mean 6
SE) of triplicate CTLL-2 cultures.
All T cell cultures were done in 200 ml of tissue culture medium
(DMEM) containing 10% FCS (Life Technologies), antibiotics, and 0.05
mM 2-ME in 96-well flat-bottom plates (Falcon, Franklin Lakes, NJ). Pro-
liferative responses of CTLL-2 cells were measured by stimulating 1 3 104
CTLL-2 cells per well with B3.4.5 culture supernatants, incubating for
24 h, and pulsing the plates with 0.5 mCi/well of [3H]thymidine (NEN Life
Science Products, Boston, MA) for 12–16 h. Plates were harvested onto
glass fiber filters for scintillation counting (Betaplate; Wallac, Turku,
Finland).
Results
SR-mediated Ag uptake enhances MHC class I-restricted
presentation by both macrophages and B cells
Peritoneal exudate cell macrophages or splenic B cells were used
to present either native OVA or maleyl-OVA in medium to the
OVA-specific H-2Kb-restricted T cell transfectant line B3.4.5. Fig.
1A shows that macrophages presented native OVA to B3.4.5,
while B cells exhibited almost no presentation. However, when
maleyl-OVA was used as the Ag, both macrophages and B cells
showed excellent presentation to B3.4.5 (Fig. 1A).
We have previously shown that both macrophages and B cells
can take up maleylated Ag via receptor-mediated uptake (32). To
confirm that the enhanced presentation of maleyl-OVA in the
present experiments was indeed receptor-mediated, various struc-
turally unrelated SR-binding competitor ligands were used to in-
hibit both OVA and maleyl-OVA presentation by macrophages or
FIGURE 1. MHC class I-restricted presentation of maleyl-OVA is bet-
ter than that of native OVA and is receptor mediated. A, Shows the re-
sponses of the MHC class I-restricted T cell line B3.4.5 to peritoneal mac-
rophages (circles) or splenic B cells (squares) presenting exogenous
maleyl-OVA (filled symbols) or native OVA (open symbols). Background
[3H]thymidine incorporation in the absence of any Ag was 2500 cpm. B,
Shows inhibition of MHC class I-restricted presentation of native and ma-
leyl-OVA by SR ligands. Peritoneal macrophages or splenic B cells were
pulsed with 100 mg/ml native OVA or maleyl-OVA in the presence or
absence (2) of 100 mg/ml of the various inhibitors shown. Background
[3H]thymidine incorporation in the absence of Ag was 1500 cpm. The data
are representative of three independent experiments.
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B cells. The known SR ligands fucoidin, polyG, and maleyl-BSA
(36, 37) all significantly inhibited the presentation of maleyl-OVA
by both macrophages and B cells, although they did not decrease
the efficiency of OVA presentation to B3.4.5 by either APC type
(Fig. 1B).
Presentation of exogenous OVA and maleyl-OVA is TAP
independent
If exogenously administered Ags were to leak into the cytosol
from endosomes and be processed there, TAP would be required
for transport of peptides into the ER lumen for binding to MHC
class I, as reported earlier (26). However, there are also reports of
the presentation of exogenous Ags being TAP independent (25,
38). To determine the role of TAP in the presentation of maleyl-
OVA, we used peritoneal macrophages from either TAP-1-KO or
wild-type mice to present either OVA or maleyl-OVA in the cul-
ture medium to B3.4.5. The results (Fig. 2A) show that TAP-1-KO
macrophages presented both native OVA and maleyl-OVA as ef-
ficiently as wild-type macrophages. They did not, however, present
cytosolically loaded OVA, establishing their mutant phenotype
(Fig. 2B).
Processing of maleyl-OVA is sensitive to endosomal pH
An alternative to the TAP-dependent cytosolic processing model
for MHC class I-restricted presentation of exogenously adminis-
tered Ags is that this processing takes place in phagosomes and the
resultant peptides are regurgitated into extracellular medium where
they associate with surface MHC class I (25). Protein processing in
the endolysosomal compartment is likely to utilize the acid pro-
teases available there (39). Some reports have shown that process-
ing of exogenous Ag is not sensitive to inhibition of endosomal
acidification (24, 26), lending weight to the argument that the ex-
ogenous Ag may leak from the phagosome/endosome to the cy-
tosol and be processed there. Since the presentation of both pino-
cytosed and receptor-binding protein in the present system was
TAP-1 independent, we examined its dependence on endosomal
acidification. Processing of exogenous native or maleyl-OVA in
the presence of ammonium chloride was assessed by pulsing H-2b
macrophages with 1 mg/ml OVA or maleyl-OVA in the presence
or absence of various concentrations of ammonium chloride for
3 h, washing and fixing the cells, and using them to stimulate
B3.4.5. The presentation of native OVA was reproducibly inhib-
ited only at 200 mM ammonium chloride, and then only partially,
but the presentation of maleyl-OVA was greatly inhibited even by
0.2 mM ammonium chloride (Fig. 3).
We next examined whether macrophages could take up and pro-
cess maleyl-OVA and regurgitate peptides for binding to surface
MHC class I (25). H-2b or H-2k macrophages were pulsed with 1
mg/ml of native or maleyl-OVA in the culture medium for 1 h,
washed, and titrated (the H-2b APCs by themselves and the H-2k
APCs in the presence of 1 3 105 H-2b macrophages per well as
bystander APCs that could potentially bind to OVA peptides re-
gurgitated by the Ag-pulsed H-2k macrophages). B3.4.5 cells were
used to detect Ag presentation as usual. Fig. 4 shows that, while
H-2b APCs could elicit a response when Ag-pulsed, they could not
do so when present as bystander APCs along with Ag-pulsed
APCs of the wrong MHC haplotype. Not only was this true of
OVA-pulsed APCs but also of maleyl-OVA-pulsed APCs, which
FIGURE 2. MHC class I-restricted presentation of exogenous native or
maleyl-OVA does not require TAP-1. A, Shows the response of the T cell
line B3.4.5 to peritoneal macrophages from TAP-1-KO (broken lines) or
wild-type (continuous lines) mice presenting native OVA (hollow circles)
or maleyl-OVA (filled circles) exogenously. B, Shows the responses of
B3.4.5 to titrated numbers of wild-type (continuous lines) or TAP-1-KO
(broken lines) peritoneal macrophages loaded cytosolically with native
OVA (10 mg/ml). Background [3H]thymidine incorporation in the absence
of Ag was 3000 cpm. The data are representative of three independent
experiments.
FIGURE 3. Processing of exogenous maleyl-OVA is more sensitive to
inhibition of endosomal acidification by ammonium chloride than process-
ing of exogenous native OVA. Peritoneal macrophages were pulsed with 1
mg/ml of native OVA (hollow circles) or maleyl-OVA (filled circles) in the
presence or absence of graded concentrations of ammonium chloride as
shown and used after washing and fixation to stimulate B3.4.5 T cells. The
inhibition of the B3.4.5 response by various doses of ammonium chloride
added to the macrophages during processing is shown. The response to
native OVA was 10,500 cpm, and that to maleyl-OVA was 30,700 cpm,
while the background counts were 2,000 cpm. The data are representative
of five independent experiments.
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triggered much higher responses when of the right haplotype
(Fig. 4).
Ammonium chloride sensitivity of maleyl-OVA presentation is
due to requirement for receptor-ligand uncoupling
We then further explored the extreme sensitivity of maleyl-OVA
presentation to the inhibition of endosomal acidification (Fig. 3).
We initially used de-maleyl-OVA in these experiments. De-ma-
leyl-OVA was presented by macrophages with greater efficiency
than native OVA, although not quite as well as maleyl-OVA (Fig.
5A). Maleyl-BSA (10 mg/ml) was used as a competitor SR ligand
with de-maleyl-OVA (100 mg/ml) to pulse H-2b macrophages,
which were washed and fixed 3 h later and used to stimulate
B3.4.5. The results (Fig. 5B) established that the enhanced effi-
ciency of presentation of de-maleyl-OVA was due to receptor-
mediated uptake. When presentation of native OVA, maleyl-OVA,
and de-maleyl-OVA was inhibited with ammonium chloride, de-
maleyl-OVA continued to be highly sensitive to 2 mM ammonium
chloride, as was maleyl-OVA, while native OVA presentation was
inhibited only by 200 mM ammonium chloride (Fig. 5C).
Next, to deliver maleyl-OVA to macrophages through pinocy-
tosis rather than through receptor-mediated endocytosis, APCs
were pulsed with maleyl-OVA (100 mg/ml) in the presence or
absence of maleyl-BSA (10 mg/ml) with or without 2 mM ammo-
nium chloride. Fig. 5D shows the results of one such experiment
expressed as percentage inhibition of the presentation of maleyl-
OVA by 2 mM ammonium chloride, and it can be seen that the
sensitivity of maleyl-OVA presentation to 2 mM ammonium chlo-
ride is decreased from 85% to 45% in the presence of competing
maleyl-BSA.
Maleyl-OVA is processed poorly as a cytosolic protein
We also used another approach to address the possibility that some
maleyl-OVA was indeed leaking into the cytosolic presentation
pathway. Native OVA or maleyl-OVA were loaded into macro-
phage cytosol via osmotic lysis of pinosomes, and these macro-
phages were then used to stimulate B3.4.5. In contrast to the find-
ings obtained when the two proteins were given exogenously,
cytosolic native OVA was well presented, but cytosolic maleyl-
OVA generated a very poor response (Fig. 6). If there had indeed
been any cytosolic leakage of exogenously administered maleyl-
OVA from endosomes, these data confirmed that such leaked ma-
leyl-OVA could not be processed cytosolically.
It was of interest to address the question of why maleyl-OVA
was so resistant to cytosolic processing. It has been shown that
processing of a cytosolic protein is inhibited by blocking potential
ubiquitination sites on it by methylation of amino groups (40).
Since maleyl residues attach primarily to amino groups, it is pos-
sible that this blocks ubiquitin-binding sites, leading to poor cy-
tosolic degradation of maleyl-OVA. However, it was also possible
that maleyl-OVA is processed by a ubiquitination-independent
pathway (41) but that the peptide repertoire generated from it and
loaded on MHC class I in the absence of demaleylation is quite
different from that generated from native OVA, and does not in-
clude the SIINFEKL sequence recognized by B3. This possibility
is reinforced by the fact that the subterminal lysine residue in the
nominal target peptide for B3.4.5 is important for TCR
contact (42, 43).
The poor processing of cytosolic maleyl-OVA could be either
due to a direct effect of the maleyl groups per se, or indirectly due
to the conformational change that maleylation imposes. It has been
shown that demaleylating maleyl-proteins still permits them to re-
tain the SR-binding conformation provided by the maleylation pro-
cess (33). This allows us to distinguish between the direct and the
indirect effects of maleyl groups on cytosolic processing, since if
the direct effect of maleyl residues was the main factor involved,
a prediction would be that de-maleyl-OVA would be better pro-
cessed cytosolically than maleyl-OVA. We therefore demaleylated
maleyl-OVA and loaded it cytosolically for presentation to B3.4.5.
Fig. 6 also shows that de-maleyl-OVA is presented much better
than maleyl-OVA, although not quite as well as native OVA itself,
through the cytosolic pathway, lending support to the probability
that the poor cytosolic processing of maleyl-OVA may be due to
blockade of ubiquitin-binding sites by the maleyl groups.
Discussion
The data here demonstrate that receptor-mediated endocytosis of a
fluid-phase protein by macrophages as well as by B cells enhances
its MHC class I-restricted presentation and that this processing and
presentation is likely to be an acidification-dependent endosomal
event.
The basis for the processing of exogenous Ags by macrophages
for presentation on MHC class I has been much debated. While
fluid-phase proteins are processed and presented by APCs of the
monocytic lineage for MHC class I-restricted presentation (27), the
efficiency of this presentation has been shown to improve mark-
edly if the Ag is taken up by phagocytosis in either Salmonellae
(44), Escherichia coli (45), acid-resistant liposomes (46), or latex
beads (25). In fact, even in unconventional APC types that have
been shown to process exogenous Ag for MHC class I, the phago-
cytic ability of the tumor cell lines involved has been speculated to
be a relevant factor (20, 23). Phagocytosis would clearly increase
the efficiency of Ag loading into APCs, and, if endosomal Ag
processing pathways for MHC class I are relatively inefficient,
increase in Ag uptake would enhance their efficacy significantly.
However, it is not clear whether the improvement in MHC class
I-restricted presentation by phagocytosis of the Ag is principally a
quantitative effect achieved by augmented Ag uptake, or whether
phagocytic uptake has qualitative effects on Ag handling. The lat-
ter possibility revolves in part around the fact that Ag delivery
FIGURE 4. MHC class I-restricted presentation of native or maleyl-
OVA does not involve peptide regurgitation. H-2b (broken lines) or H-2k
(continuous lines) peritoneal macrophages pulsed with 1 mg/ml of native
(hollow circles) or maleyl-OVA (filled circles) in the culture medium for
1 h were washed and titrated with B3.4.5 cells (the H-2b APCs by them-
selves and the H-2k APCs in the presence of 1 3 105 H-2b macrophages per
well). Background [3H]thymidine incorporation in the absence of Ag was
2000 cpm. The data are representative of two independent experiments.
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vehicles for phagocytosis used in some of these experiments, such
as latex beads or iron beads, induce rupturing of the phagosomal
membrane, leading to discharge of the endosomal contents into the
cytosol, followed by conventional proteasomal processing for pep-
tide loading on MHC class I (23). An allied possibility suggested
has been that a unique cell biological property of endocytosis in
macrophages, namely macropinocytosis, may be crucial in permit-
ting them to present exogenous Ags on MHC class I, since mac-
ropinosomes, again, are leaky and can deliver their contents to the
cytosol (38, 47).
If the quantitative effects of phagocytosis in enhancing Ag up-
take are more important than the qualitative effects of phagosome
or macropinosome leakiness, receptor-mediated endocytosis,
which would provide the quantitative improvements but not the
qualitative alterations, should be adequate to enhance MHC class
I-restricted presentation of exogenously administered Ags by mac-
rophages. SRs on macrophages are known to internalize bound
ligand rapidly and to deliver it efficiently to the lysosomes (48) and
such receptor-mediated endosomes are not known to be leaky (49).
We have already reported that SR-mediated presentation of protein
Ags improves their presentation on MHC class II (30). We have
therefore used SR-specific delivery of an exogenous protein to test
the dominance of quantitative vs qualitative effects in MHC class
I-restricted exogenous Ag presentation. Our data provide evidence
that delivering OVA to receptors with SR-like ligand specificities
by maleylating it enhances its presentation on MHC class I and
that this is dependent on receptor binding, since the enhancement
is inhibited by multiple structurally unrelated competing SR li-
gands (Fig. 1). Clearly, the quantitative enhancement of Ag uptake
by receptor-mediated endocytosis is adequate to permit better en-
dosomal MHC class I-restricted presentation, and phagosomes or
macropinosomes are unlikely to be unique compartments permit-
ting access to the peptide-loading pathway for MHC class I.
Further, presentation of exogenous Ags on MHC class I is
clearly not a unique property of macrophages, since B cells present
receptor-bound exogenous Ag efficiently. In fact, we find that B
cell tumor lines also show similar properties (data not shown), thus
eliminating any chances that contaminating macrophages were re-
sponsible for the enhanced presentation of maleyl-OVA by puri-
fied B cell populations (Fig. 1). While the classical SRs, SR-AI/II,
are found almost exclusively on monocytic cells, other members of
the SR superfamily such as CD36 or CD5 are found at least on
subsets of B cells (50, 51). There are other, less well-characterized
molecules expressing SR-related cysteine-rich domains expressed
by B and other lymphoid cells (52, 53). Further, dG-oligomers,
related to the SR ligand polyG, are also reported to stimulate
mouse B cells by direct binding (54–56), although the receptor has
not been characterized. It therefore appears probable that a variety
FIGURE 5. The sensitivity of exogenous maleyl-
OVA presentation to ammonium chloride is depen-
dent on receptor-ligand decoupling rather than ma-
leylation per se. A, Shows the response of B3.4.5
cells to titrated doses of native OVA (hollow circles),
maleyl-OVA (filled circles), and de-maleyl-OVA
(hollow squares) presented by peritoneal macro-
phages. Background [3H]thymidine incorporation in
the absence of Ag was 5000 cpm. B, Shows the re-
sponse of B3.4.5 cells to titrated numbers of perito-
neal macrophages pulsed with 100 mg/ml de-maleyl-
OVA in the presence (filled squares) or absence
(hollow squares) of 10 mg//ml of maleyl-BSA. Back-
ground [3H]thymidine incorporation in the absence
of Ag was 4000 cpm. C, Shows the responses of
B3.4.5 to peritoneal macrophages pulsed with 1
mg/ml of native, maleyl-, or de-maleyl-OVA as
shown in the presence of various doses of ammonium
chloride (0 mM, hollow bars; 2 mM, hatched bars;
200 mM, stippled bars). Background counts in the
absence of Ag were 4000 cpm. D, Shows the per-
centage inhibition in the response of B3.4.5 cells due
to the presence of 2 mM ammonium chloride during
macrophage APC pulsing with 100 mg/ml maleyl-
OVA in the presence or absence of 10 mg/ml maleyl-
BSA as shown. The data are representative of three
independent experiments.
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of pattern-recognition receptors of the SR superfamily with dis-
tinct but overlapping ligand specificities may be present on B cells.
Our data showing enhanced presentation of maleylated proteins on
MHC class II (32) or class I (Fig. 1) are consistent with this pos-
sibility. Thus, receptor-specific delivery of exogenous protein Ags
to any APC may lead to enhanced MHC class I-restricted presen-
tation, suggesting that the exogenous pathway of peptide loading
for MHC class I may be a constitutive property dependent mainly
on the quantity of Ag taken up by the APC.
Our finding that endosomal bodies with specialized leaky prop-
erties such as phagosomes or macropinosomes are not absolutely
required for MHC class I-restricted presentation of exogenous pro-
teins also bears on the question of the pathway of processing in-
volved, since it becomes more likely that this is purely endosomal
rather than cytosolic. Both endosomal and cytosolic pathways have
been invoked in various reports for the phenomenon, phagosomal
processing followed by peptide regurgitation for binding to cell
surface MHC class I (25), or leaky phagosomes or macropino-
somes delivering protein to the cytosolic proteasome-TAP-medi-
ated classical pathway (23, 26). There are a number of points in
our data suggesting that the processing of Ag taken up by macro-
phages via receptor-mediated endocytosis is in fact endosomal.
Processing and presentation of exogenous maleyl-OVA is very
sensitive to ammonium chloride (Fig. 3), which serves to neutral-
ize the low pH in maturing endosomes and inhibits endosomal
processing (1). This shows that exogenous maleyl-OVA needs to
be retained in the endosomes until exposure to the low pH of late
endosomal compartments to gain access to the peptide-loading
pathway for MHC class I. While it has been reported that ammo-
nium chloride can also inhibit cytosolic processing of OVA (57),
the probability of its effects being mainly endosomal in the current
data is supported by the finding that maleyl-OVA, when directly
introduced into the cytosol, virtually cannot be processed for MHC
class I-restricted presentation (Fig. 6). Clearly, if unprocessed ma-
leyl-OVA in the cytosol cannot be proteasomally processed to gen-
erate SIINFEKL, leakage of maleyl-OVA from the endosomes to
the cytosol is unlikely to be responsible for its MHC class I-re-
stricted presentation.
We have attempted to examine the basis of the exquisite sensi-
tivity of maleyl-OVA presentation to ammonium chloride in com-
parison with native OVA. One explanation for this sensitivity is
that successful processing requires demaleylation of the maleyl-
protein, which is known to take place at acidic pH (33). This is
unlikely to be an explanation, since de-maleyl-OVA is also sen-
sitive to ammonium chloride (Fig. 5). Demaleylated proteins have
been reported to maintain the ability to bind to SRs despite the loss
of maleyl groups (33). In keeping with those reports, there is en-
hanced presentation of de-maleyl-OVA as well via SRs (Fig. 5).
Since the presence of maleyl groups was thus ruled out as a cause
for the sensitivity of maleyl-OVA presentation to 2 mM ammo-
nium chloride, we next examined whether this sensitivity was due
to the maleyl-OVA being receptor bound. Converting the mode of
delivery of maleyl-OVA from a receptor-mediated one to a pino-
cytic one by using an excess of an SR-binding competitor does
reduce its sensitivity to 2 mM ammonium chloride (Fig. 5), al-
though the decrease, while consistently seen in multiple experi-
ments, is not dramatic. This suggests that at least part of this sen-
sitivity may be due to the dependence of receptor-ligand
uncoupling on acidification.
It can be argued that there is some amount of leakage of maleyl-
OVA after demaleylation and degradation even from acidic endo-
somes to the cytosol for proteasomal degradation. If such maleyl-
OVA-derived peptides were generated endosomally and then
delivered to the cytosol for MHC class I loading, their transport
from the cytosol to the ER would be TAP dependent (4–6). To test
this possibility, we have used macrophages from TAP-1-KO mice
as APCs to present native or maleyl-OVA to the MHC class I-re-
stricted T cell line B3.4.5. We find that TAP-1-KO macrophages
present both Ags as efficiently as TAP-1-sufficient macrophages do
(Fig. 2). This suggests that neither exogenous proteins nor peptides
generated from exogenous fluid-phase or receptor-binding proteins
are transferred to the cytosol for MHC class I loading.
Previous demonstrations of endosomal processing for MHC
class I-restricted presentation have argued for a peptide regurgita-
tion model in which peptides are thrown out into the medium and
bound to cell surface MHC class I (25). We have examined this
possibility in our experimental system using bystander H-2b mac-
rophages to present peptides processed and regurgitated by non-
H-2b macrophages pulsed with Ag, but have been unable to detect
any such regurgitation (Fig. 4). While the endosomal pathway for
MHC class I-restricted presentation seen here may not be the only
such pathway, given the many reports of cytosolic generation of
peptides from exogenous proteins, our data make it probable that
processing as well as MHC class I loading of peptides from re-
ceptor-binding proteins may take place predominantly in the en-
dosomal compartment.
Another point of interest in our data relates to the basis for the
nonprocessing of maleyl-OVA when introduced directly into the
cytosol (Fig. 6). There are two possible explanations, not neces-
sarily mutually exclusive. One is that maleyl-OVA is simply not
processed well by the proteasomal route at all. The other possibil-
ity is that it is indeed processed but does not generate the SIIN-
FEKL peptide, either because a completely different peptide rep-
ertoire is generated, or at least because maleyl-SIINFEKL (peptide
maleylated at the subterminal lysine residue) is generated. The
subterminal lysine residue in SIINFEKL has been shown to be
essential for recognition by the TCR of B3.4.5, although it is not
needed for H-2Kb binding (42, 43, 58). Interestingly, maleylation
of this lysine residue abrogates binding of the peptide to H-2Kb
(data not shown), suggesting that influences on peptide conforma-
tion by non-MHC-contacting amino acid residues may modulate
peptide repertoires of MHC molecules. However, it also appears
FIGURE 6. Cytosolic maleyl-OVA is presented very poorly to B3.4.5
due to the presence of maleyl residues. Responses of B3.4.5 cells to peri-
toneal macrophages cytosolically loaded with 10 mg/ml of native OVA
(hollow circles), maleyl-OVA (filled circles), or de-maleyl-OVA (hollow
squares) by osmotic lysis of pinosomes are shown. Background counts in
the presence of mock-loaded APCs were 2000 cpm. The data are repre-
sentative of five independent experiments.
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that maleyl-OVA is not processed well by the proteasomal route,
since maleyl-OVA-loaded spleen cells used for priming in vivo
cannot generate a CTL response even against maleyl-OVA (data
not shown). Of the two possible explanations for this, 1) that the
altered conformation that permits the maleyl-protein to bind SRs
(33) also inhibits proteasomal processing, and 2) that the presence
of the maleyl groups directly hinders processing, our data suggest
that the latter is correct, since maleyl-protein demaleylation, which
is known to spare the SR-binding capability, nonetheless restores
cytosolic processing (Fig. 6). Maleylation is mainly directed at the
e-amino groups of lysine residues in the protein being maleylated
(33), and it is the methylation of precisely these groups that is
needed for the binding of ubiquitin (2). These data therefore sup-
port the dominant role played by ubiquitination in delivering cy-
tosolic proteins to the proteasomal degradatory pathway shown
earlier (40), although there have also been reports of ubiquitina-
tion-independent pathways of cytosolic protein degradation (41).
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